These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6233382)

  • 41. Functional characterization of a regulatory human T-cell subpopulation increasing during autologous MLR.
    Cosulich ME; Risso A; Canonica GW; Bargellesi A
    Immunology; 1986 Feb; 57(2):265-73. PubMed ID: 2936679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
    Otsuka T; Okamura S; Niho Y; Kusaba T
    J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus.
    Pan HF; Ye DQ; Li XP
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):352-3. PubMed ID: 18477998
    [No Abstract]   [Full Text] [Related]  

  • 44. Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man.
    Gatenby PA; Kansas GS; Xian CY; Evans RL; Engleman EG
    J Immunol; 1982 Nov; 129(5):1997-2000. PubMed ID: 6214586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The regulation of antibody secreting cells generated in the autologous mixed leukocyte reaction in man.
    Gatenby PA; Engleman EG
    Behring Inst Mitt; 1983 May; (72):143-52. PubMed ID: 6152687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of T-lymphocyte and killer-cell defects in the pathogenesis of systemic lupus erythematodes].
    Wollina U
    Dermatol Monatsschr; 1983; 169(12):749-61. PubMed ID: 6230266
    [No Abstract]   [Full Text] [Related]  

  • 47. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
    Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
    Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocyte transformation induced by autologous cells.
    Weksler ME; Kuntz MM; Birnbaum G; Innes JB
    Fed Proc; 1978 Aug; 37(10):2370-3. PubMed ID: 79505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the lymphocyte subpopulation in systemic lupus erythematosus by monoclonal antibodies.
    Surányi P; Sonkoly I; Szegedi G
    Immunol Lett; 1983; 7(2):57-60. PubMed ID: 6228522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.
    Gupta S; Fikrig SM; Mariano E; Quazi Q
    Clin Exp Immunol; 1983 Jul; 53(1):25-30. PubMed ID: 6223734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Double-stranded DNA antibodies and lymphocyte subpopulations in disseminated lupus erythematosus].
    Rodeck U; Kreuzfelder E; Kuwert E; Rupprecht HJ; Brittinger G; Laubenthal F
    Med Welt; 1983 Jun; 34(24):692-3. PubMed ID: 6224999
    [No Abstract]   [Full Text] [Related]  

  • 53. Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.
    Kaneoka H; Morito F; Yamaguchi M
    J Clin Lab Immunol; 1989 Jan; 28(1):15-26. PubMed ID: 2470907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lymphocyte subpopulations responsible for defective autologous mixed lymphocyte reactions in patients with systemic lupus erythematosus: analysis of lymphocytes obtained from three sets of identical twins and the family members (author's transl)].
    Sakane T; Honda M; Koh T; Taniguchi Y; Kotani H
    Arerugi; 1981 May; 30(5):227-34. PubMed ID: 6211162
    [No Abstract]   [Full Text] [Related]  

  • 55. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Symposium on mechanisms of host defense from fundamental and clinical medicine. 4. Significance of autologous mixed lymphocyte reaction-activated immune circuits for maintaining normal immune homeostasis in humans].
    Sakane T
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1756-61. PubMed ID: 6241937
    [No Abstract]   [Full Text] [Related]  

  • 57. Significance of autologous mixed lymphocyte reaction-activated immune circuits for maintaining normal immune system homeostasis in humans.
    Sakane T
    Jpn J Med; 1985 May; 24(2):188-90. PubMed ID: 3160876
    [No Abstract]   [Full Text] [Related]  

  • 58. [Autologous mixed lymphocyte reaction in systemic lupus erythematosus].
    Chang ZN; Tsai LC; Chang LD; Lan JL; Han SH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):240-6. PubMed ID: 2935373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.
    Stephens HA; Fitzharris P; Knight RA; Snaith ML
    Ann Rheum Dis; 1982 Oct; 41(5):495-501. PubMed ID: 6215003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antilymphocyte antibodies and systemic lupus erythematosus.
    Morimoto C; Schlossman SF
    Arthritis Rheum; 1987 Feb; 30(2):225-8. PubMed ID: 2950863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.